Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Nanjing Zeheng Pharmaceutical Technology Development is a comprehensive pharmaceutical R&D enterprise based in Nanjing, China, specializing in the discovery and development of innovative drugs and high-end generic medications. Founded in 2011, the company operates as both a biotech developer and a service provider (CRO/CDMO), offering expertise in drug design, chemical synthesis, formulation development, and clinical trial management. Zeheng Pharma maintains a robust pipeline focused on metabolic diseases, oncology, and cardiovascular health, with several candidates in clinical stages. The company is particularly recognized for its capabilities in consistency evaluation for generic drugs and its integrated technology platforms that support the entire drug development lifecycle from laboratory to industrialization.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Nanjing Zeheng Pharmaceutical Technology Development.